Holen Sie sich die Stockscreener-App
1.49
0.00%
0.00
Handel nachbörslich:
1.50
0.01
+0.67%
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics Awards Stock Units to New Employee Bill Leonard - MSN
Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt - Simply Wall St
HighTower Advisors LLC Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com
Neuronetics Revamps TrakStar System, Streamlining Patient Data Management - MSN
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Grants Strategic 50,000 PRSU Inducement Award to Key New Employee - StockTitan
Neuronetics' SWOT analysis: merger impact on neurohealth stock By Investing.com - Investing.com Australia
Neuronetics Unveils Strategic Performance-Based Stock Awards Targeting Cash Flow Breakeven by 2025 - StockTitan
Neuronetics' SWOT analysis: merger impact on neurohealth stock - Investing.com
Neuronetics, Greenbrook TMS close transaction - Medical Buyer
Neuronetics Expands with Greenbrook TMS Acquisition - TipRanks
Madryn Provides Update on Holdings of Greenbrook TMS Inc. - The Manila Times
Neuronetics and Greenbrook TMS Announce Closing of Transaction - The Manila Times
Reviewing Stryker (NYSE:SYK) & Neuronetics (NASDAQ:STIM) - Defense World
Neuronetics' SWOT analysis: merger, market challenges shape TMS stock outlook - Investing.com Nigeria
Neuronetics (STU:NRC) 3-Year EPS without NRI Growth Rate : 9.40% (As of Sep. 2024) - GuruFocus.com
Neuronetics (STU:NRC) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com
Greenbrook TMS Q3 Revenue Up 9% to $18.9M, Plans to Close 23 Centers Amid Merger - StockTitan
Transcranial Magnetic Stimulator Market Overall Study Report - openPR
GSA Capital Partners LLP Purchases 30,837 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Transcranial Magnetic Stimulator Market Future Business - openPR
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics - TipRanks
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval - MSN
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Neuronetics to Present at Piper Sandler Healthcare Conference in December 2024 | STIM Stock News - StockTitan
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MSN
Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12% - Simply Wall St
Neuronetics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025 - Yahoo Finance
William Blair Decreases Earnings Estimates for Neuronetics - Defense World
Greenbrook TMS Acquisition by Neuronetics Approved - TipRanks
Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Neuronetics regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc - GuruFocus.com
Neuronetics Inc. (STIM) Quarterly 10-Q Report - Quartzy
Earnings call: Neuronetics reports revenue growth amidst strategic shifts By Investing.com - Investing.com Australia
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Neuronetics regains Nasdaq compliance with bid price - Investing.com
Earnings call: Neuronetics reports revenue growth amidst strategic shifts - Investing.com
Neuronetics, Inc. (NASDAQ:STIM) Q3 2024 Earnings Call Transcript - Insider Monkey
Neuronetics announces inducement grant - Medical Buyer
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):